Divis Laboratories Earnings

• 

  Divi's Labs Shares Decline Over 6% After Q4 Earnings

  Shares of Divi's Laboratories fell more than 6 per cent on Tuesday as the company's March quarter earnings failed to cheer investors. The stock dropped as much as 6.35 per cent to hit an intraday low of Rs 3,650.

• 

  Divis Lab Slumps 20% After US Regulator Issues Import Alert For Vizag Plant

  Surjit Pal, pharma analyst at Prabhudas Lilladher, says Divis Lab shares could remain under pressure as its FY18 earnings would be hit due to the import alert.

• 

  Divis Labs Q2 Net Down 24.6% At Rs 224 Crore

  Divis Laboratories reported a 24.60 per cent dip in its standalone net profit to Rs 223.85 crore for the quarter ended September 30, 2016 mainly on account of increased expenses.

• 

  Divis Laboratories Slumps 5% on Q3 Earnings

  Divis Lab also took a hit on the profitability front in the December quarter. Its operating margins fell 120 basis points sequentially to 37.8 per cent on account of an increase in employee cost, following provisions for bonuses.

• 

  Divis Laboratories Q3 Net Up Nearly 12% at Rs 246 Crore

  Pharmaceuticals firm Divis Laboratories on Friday reported an 11.77 per cent rise in standalone net profit at Rs 246.56 crore for the quarter ended December 31, 2015.

• Divis Laboratories Posts 29% Rise in Q2 Net

  Divis Laboratories on Saturday reported a 28.77 per cent rise in standalone net profit at Rs 295.73 crore for the fiscal second quarter that ended on September 30, 2015.

• Divis Labs Q1 Net Spurts 45% to Rs 243 Crore

  Net sales of the company rose to Rs 806.91 crore for the first quarter as against Rs 639.76 crore in the year-ago quarter, Divis Laboratories said in a filing to BSE.

• Divi's Laboratories Q1 Net Down 3.8 Per Cent at Rs 167.93 Crore

  Drug firm Divi's Laboratories on Monday reported a standalone net profit of Rs 167.93 crore for the first quarter that ended on June 30, 2014.

• Divi's Lab surges after December quarter earnings beat

  The company on Monday reported a 51.84 per cent increase in its standalone net profit at Rs 219 crore for the October-December quarter.

• Divi's Laboratories Q2 net up 74 per cent at Rs 205 crore

  Drug firm Divi's Laboratories on Friday posted a 73.71 per cent rise in net profit at Rs 204.93 crore for the quarter ended September 30.

• Divis Labs Q1 net rises 4 per cent to Rs 174 crore

  Drug firm Divis Laboratories on Saturday reported a 4.37 per cent rise in its net profit at Rs 174.71 crore for the quarter ended June 30, 2013, on account of robust sales and increase in forex gains.

• Divi's Lab Q4 profit up 24% at Rs 217 cr on robust sales

  Drug firm Divi's Laboratories today said its consolidated net profit rose by 23.81 per cent to Rs 216.91 crore for the fourth quarter ended December 31, 2012, on account of robust sales during the quarter.

• Divi's Laboratories Q3 profit up 20.65% at Rs 122.55 crore

  Total income of the company stood at Rs 417.42 crore for the quarter ended December 31, 2011